[HTML][HTML] Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - BMC biomedical engineering, 2019 - Springer
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - BMC biomedical engineering, 2019 - pubmed.ncbi.nlm.nih.gov
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
Developing preclinical models of neuroblastoma: driving therapeutic testing.
KJ Ornell, JM Coburn - BMC Biomedical Engineering, 2019 - europepmc.org
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
[HTML][HTML] Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - BMC …, 2019 - bmcbiomedeng.biomedcentral.com
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
[HTML][HTML] Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - BMC Biomedical Engineering, 2019 - ncbi.nlm.nih.gov
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - BMC Biomedical Engineering, 2019 - search.proquest.com
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
[PDF][PDF] Developing preclinical models of neuroblastoma: driving therapeutic testing
KJ Ornell, JM Coburn - 2019 - bmcbiomedeng.biomedcentral.com
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology,
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …
successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common …